Loading...
•
Dec 31, 2020
Bio-Techne Q2 2021 Earnings Report
Bio-Techne's Q2 2021 results were released, demonstrating strong organic growth and profitability.
Key Takeaways
Bio-Techne reported a 21% increase in net sales to $224.3 million, with organic growth of 19%. GAAP EPS was $1.15, while adjusted EPS reached a record $1.62. The adjusted operating margin improved to 38.7%.
Second quarter organic revenue increased by 19% (21% reported) to $224.3 million.
GAAP EPS was $1.15, and adjusted EPS was a record $1.62.
Adjusted Operating Margin increased to 38.7%.
Both the Protein Sciences and Diagnostics and Genomics segments delivered record organic growth of 19%.
Bio-Techne
Bio-Techne
Bio-Techne Revenue by Segment
Revenue by Segment
Protein Sciences Revenue
CapyFin.comDiagnostics & Spatial Bio Revenue
CapyFin.comRevenue & Expenses
Visualization of income flow from segment revenue to net income